Imaging Biomarkers in Immunotherapy
Rosalyn A. Juergens(McMaster University), Karen Y. Gulenchyn(McMaster University), Amit Singnurkar(McMaster University), John F. Valliant(McMaster University), Katherine Zukotynski(Unknown), Denis P. Snider(McMaster University)
Cited by 47
Related Papers
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
|Journal of Clinical Oncology|2013|594
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
|The Lancet Oncology|2020|190
Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management
|American Journal of Roentgenology|2012|109
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma
|Annals of Oncology|2010|105
Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT
|CHEST Journal|2007|100